Troluce Capital Advisors’s Core Scientific CORZ Stock Holding History

Troluce Capital Advisors’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25.4M	Buy	+1,697,090	New	+$28.9M	1.56%	21
2025 Q3	–	Sell	-25,000	Closed	-$427K	–	39
2025 Q2	$427K	Sell	25,000 -1,750,000	-99%	-$17.5M	0.1%	29
2025 Q1	$12.9M	Buy	+1,775,000	New	+$20.2M	3.83%	10
2024 Q4	–	Sell	-1,325,000	Closed	-$15.7M	–	47
2024 Q3	$15.7M	Buy	1,325,000 +170,450	+15%	+$1.77M	0.92%	23
2024 Q2	$10.7M	Sell	1,154,550 -95,450	-8%	-$488K	1.05%	34
2024 Q1	$4.42M	Buy	+1,250,000	New	+$4.33M	0.54%	53

Other funds holding CORZ

Situational Awareness San Francisco, California $13.7B AUM 334.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

JCAM

Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return

OCM

Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return

Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

Troluce Capital Advisors's CORZ Position: Q1 2026 in Review

Troluce Capital Advisors opened a new position in Core Scientific (CORZ) in Q1 2026: 1,697,090 shares worth $25.4M. The stake represents 1.56% of the portfolio and ranks #21 among its holdings. This is a return to the name: Troluce Capital Advisors previously reported a position in CORZ as recently as Q2 2025.

Troluce Capital Advisors first reported a position in CORZ in Q1 2024 and has held it in 6 quarters since. 386 funds tracked by Wall St. Rank hold CORZ as of Q1 2026.

Troluce Capital Advisors held 1,697,090 shares of Core Scientific worth $25.4M as of Q1 2026.
Core Scientific was a new Troluce Capital Advisors position in Q1 2026.
Core Scientific made up 1.56% of Troluce Capital Advisors's portfolio in Q1 2026, its #21 holding.
Troluce Capital Advisors first reported a position in Core Scientific in Q1 2024 and has held it in 6 quarters since.
386 funds tracked by Wall St. Rank held Core Scientific as of Q1 2026.

Based on Troluce Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.